S

Sunzen Biotech Bhd
KLSE:SUNZEN

Watchlist Manager
Sunzen Biotech Bhd
KLSE:SUNZEN
Watchlist
Price: 0.26 MYR Market Closed
Market Cap: 212m MYR
Section:
 

Relative Value

The Relative Value of one SUNZEN stock under the Base Case scenario is 0.16 MYR. Compared to the current market price of 0.26 MYR, Sunzen Biotech Bhd is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SUNZEN Relative Value
Base Case
0.16 MYR
Overvaluation 39%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

2.5
P/S
P/S
Price to Sales
2.5
vs History
15
vs Industry
30
Median 3Y
2.3
Median 5Y
1.8
Industry
1.1
More Details
71.9
P/E
P/E
Price to Earnings
71.9
vs History
23
vs Industry
20
Median 3Y
37.6
Median 5Y
37
Industry
17.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
25
Median 3Y
-4.5
Median 5Y
-4.5
Industry
11.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
29
Median 3Y
-4.1
Median 5Y
-4.3
Industry
15.6
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
61
vs Industry
37
Median 3Y
1.4
Median 5Y
1.4
Industry
1.5
More Details
2.5
EV/S
EV/S
Enterprise Value to Sales
2.5
vs History
14
vs Industry
35
Median 3Y
2.1
Median 5Y
1.5
Industry
1.2
More Details
7.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.9
vs History
33
vs Industry
29
Median 3Y
5.7
Median 5Y
0
Industry
4
More Details
23.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.8
vs History
11
vs Industry
32
Median 3Y
14
Median 5Y
13.5
Industry
10.4
More Details
32.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.8
vs History
15
vs Industry
32
Median 3Y
18
Median 5Y
18
Industry
13.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
28
Median 3Y
-4.3
Median 5Y
-4.3
Industry
12.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
28
Median 3Y
-8.5
Median 5Y
-4.4
Industry
15.7
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
52
vs Industry
32
Median 3Y
1.3
Median 5Y
1.3
Industry
1.2
More Details

Multiples Across Competitors

SUNZEN Competitors Multiples
Sunzen Biotech Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Sunzen Biotech Bhd
KLSE:SUNZEN
200.8m MYR 2.5 71.9 23.8 32.8
FR
L'Oreal SA
PAR:OR
196.1B EUR 4.5 32 18.6 22.6
UK
Unilever PLC
LSE:ULVR
116.8B GBP 2.2 23.5 185 214.9
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR 8.9 52.3 38 42
UK
HALEON PLC
LSE:HLN
34.1B GBP 3 23.6 14.2 16.1
US
Estee Lauder Companies Inc
NYSE:EL
39.5B USD 2.7 -42.5 21.4 35.4
DE
Beiersdorf AG
XETRA:BEI
21B EUR 2.1 23.8 11.8 15.1
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.7 11.3 17.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 8.6 70.4 43.7 48
IN
Dabur India Ltd
NSE:DABUR
922.2B INR 7.2 51 38.3 47.4
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
P/E Multiple
Earnings Growth PEG
MY
S
Sunzen Biotech Bhd
KLSE:SUNZEN
Average P/E: 41.4
71.9
N/A N/A
FR
L'Oreal SA
PAR:OR
32
8%
4
UK
Unilever PLC
LSE:ULVR
23.5
15%
1.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
52.3
8%
6.5
UK
HALEON PLC
LSE:HLN
23.6
12%
2
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -42.5 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
23.8
8%
3
JP
Kao Corp
TSE:4452
23.7
13%
1.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
70.4
19%
3.7
IN
Dabur India Ltd
NSE:DABUR
51
12%
4.2
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
MY
S
Sunzen Biotech Bhd
KLSE:SUNZEN
Average EV/EBITDA: 40.6
23.8
N/A N/A
FR
L'Oreal SA
PAR:OR
18.6
5%
3.7
UK
Unilever PLC
LSE:ULVR
185
1%
185
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
38
8%
4.7
UK
HALEON PLC
LSE:HLN
14.2
4%
3.6
US
Estee Lauder Companies Inc
NYSE:EL
21.4
15%
1.4
DE
Beiersdorf AG
XETRA:BEI
11.8
-1%
N/A
JP
Kao Corp
TSE:4452
11.3
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
43.7
13%
3.4
IN
Dabur India Ltd
NSE:DABUR
38.3
11%
3.5
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
MY
S
Sunzen Biotech Bhd
KLSE:SUNZEN
Average EV/EBIT: 49.2
32.8
N/A N/A
FR
L'Oreal SA
PAR:OR
22.6
6%
3.8
UK
Unilever PLC
LSE:ULVR
214.9
1%
214.9
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
42
9%
4.7
UK
HALEON PLC
LSE:HLN
16.1
4%
4
US
Estee Lauder Companies Inc
NYSE:EL
35.4
25%
1.4
DE
Beiersdorf AG
XETRA:BEI
15.1
-2%
N/A
JP
Kao Corp
TSE:4452
17.3
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
48
13%
3.7
IN
Dabur India Ltd
NSE:DABUR
47.4
11%
4.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A

See Also

Summary
SUNZEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
SUNZEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SUNZEN stock valuation using valuation multiples.
Wall Street Estimates
SUNZEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SUNZEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.